Latest News for: Executive nda

Edit

BJP-MNF joint legislator party stake claim to form govt in Mizoram

Hindustan Times 30 Nov 2022
Also Read ... MNF is a member of the BJP-led NEDA and is an ally of the NDA government headed by Prime Minister Narendra Modi at the Centre. Moreover, as for the post of chief executive member (CEM), Laikaw said that the CEM post or executive body has to be formed within 48 hours of the removal of the existing government as per the rule ... Malvina ... ....
Edit

Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy

The Galveston Daily News 17 Nov 2022
Sblendorio, Chief Executive Officer of Iveric Bio. “We are now focused on the execution of our full NDA submission and launch preparation, with the possibility of being first to market ... The company is on track to complete the final part of the NDA submission by the end of this year.
Edit

CHPS compound constructed for Kafaba community

Business Ghana 16 Nov 2022
Inaugurating the facility, the Deputy Chief Executive Officer of NDA in-charge of Projects and Programmes, Stephen Yir-eru Engmen, said the facility formed part of the authority’s commitment to provide quality healthcare delivery to the door steps of the people in its operational areas.
Edit

Unicycive Announces Third Quarter Financial Results and Provides Business Update

Eagle-Tribune 14 Nov 2022
We remain on track to file a New Drug Application (NDA) in 2023,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive ... “We continue to execute our strategy and remain excited about the opportunities ahead for Unicycive as we advance our clinical studies and expand access to RENAZORB globally.
Edit

Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates

Longview News-Journal 14 Nov 2022
"This has been an important year for Sage, marked by the execution of significant milestones across our franchises. Looking ahead, we remain focused on the completion of the NDA submission for zuranolone in MDD and PPD, and are well into commercialization preparations to support a potential launch.
Edit

HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in Second-Line Gastric Cancer in China

Pharmiweb 14 Nov 2022
HCM, HKEX ... Our team will continue to analyze the data and discuss these findings with the NMPA for possible NDA filing,” said Dr Weiguo Su, Chief Executive Officer and Chief Scientific Officer of HUTCHMED ... HUTCHMED is responsible for development and execution of all on-the-ground medical detailing, promotion and local and regional marketing ... The U.S ... .
Edit

AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Victoria Advocate 14 Nov 2022
We have progressed our lead nafamostat product candidate, Niyad™ to prepare for a potential Emergency Use Authorization in the first half of 2023 and initiated early commercial planning to ensure we're prepared for a potential launch next year," stated Vince Angotti, Chief Executive Officer of AcelRx.
Edit

BioLineRx Announces U.S. FDA Acceptance of New Drug Application for APHEXDA® (motixafortide) in Stem Cell Mobilization

Victoria Advocate 10 Nov 2022
- NDA submission based on ... "APHEXDA has the potential to significantly improve outcomes and treatment experiences for patients with multiple myeloma, and the acceptance of our NDA brings us closer to this important goal," said Philip Serlin, Chief Executive Officer of BioLineRx.
Edit

PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma

The Facts 09 Nov 2022
Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said ... Under the terms of the agreement, Avillion became the trial sponsor responsible for executing and funding the multicenter, global clinical trial program for PT027 through NDA filing to a regulatory decision in the US.
Edit

Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress

Eagle-Tribune 08 Nov 2022
“This has been an important year for Sage, marked by the execution of significant milestones across our franchises. Looking ahead, we remain focused on the completion of the NDA submission for zuranolone in MDD and PPD, and are well into commercialization preparations to support a potential launch.
Edit

Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results

Eagle-Tribune 07 Nov 2022
“With the THRIVE-AA clinical program completed and positive Phase 3 results in hand for deuruxolitinib in alopecia areata, we are well on our way to meeting our goal of submitting the NDA in the first half of 2023,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.
Edit

Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol ...

The Facts 04 Nov 2022
Food and Drug Administration (FDA) the first part of its New Drug Application (NDA) for rolling review of avacincaptad pegol (ACP, also known as Zimura®) a novel investigational complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary to Age-Related Macular Degeneration (AMD) ... Sblendorio, Chief Executive Officer of Iveric Bio.
Edit

CM criticises Modi, says Centre does not believe in democracy

The Times of India 04 Nov 2022
They (NDA leaders) are executing unfortunate works in the country and the nation would never forgive them who are silent at such activities (violence, harassment) occurring in their respective ...
Edit

Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for ...

Eagle-Tribune 04 Nov 2022
DALLAS, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc ... Results from this trial will be used to support a U.S ... The APEX clinical program will be an important element in a robust safety and efficacy database to support our VT-X7 NDA,” said David Thompson, President and Chief Executive Officer of Osteal ... About VT-X7 ... www.ostealtx.com. Contact ... .
Edit

Sharon Weston Broome: Trust and cooperation are the rule for progress in Baton Rouge

The Advocate 25 Oct 2022
Let me first say I take my integrity very seriously ... On Aug ... I did not sign an NDA and I do not believe an NDA should exist between government agencies. This incident highlights the very reason why my office needs its own executive counsel, so that I can receive a second opinion on matters and avoid legal misinformation in the future ... .

Most Viewed

Meeting between Prime Minister Sanna Marin and Chancellor Scholz on 16 March 2022
Flickr / FinnishGovernment / CC BY 2.0 https://creativecommons.org/licenses/by/2.0/
File - Europol building, The Hague, the Netherlands, is the headquarters of Europol, a European organization, in which national police forces cooperate, similar to Interpol.
Creative Commons / OSeveno https://creativecommons.org/licenses/by-sa/3.0/deed.en
×